Morning research
https://t.me/stockradarGapping down
In reaction to disappointing earnings/guidance:
- CAL -10.6%,GES -10%,FRO -7%,DRYS -6.2%,HPE -4.7%, (also announces effective February 1, 2018, Antonio Neri, current President of HPE, will become President and CEO, and will join the HPE Board of Directors),HPQ -4.7%,QADA -2.4%,CRM -1%
M&A news:
- RLOG -36.2% (to be aquired by private equity firm American Industrial Partners)
- ROK -1.3% (Rockwell Automation rejects latest unsolicited acquisition proposal from Emerson)
Other news:
- CHFS -25.5% (filing a Form EFFECT (Notice of Effectiveness for an S-1) for a possible $9 mln offering)
- PTLA -2.1% (receives extension from FDA for the review period for the Co's Prior Approval Supplement for Bevyxxa)
- TYHT -1.8% (files for $25 mln mixed securities shelf offering)
Analyst comments:
- MNK -1.8% (downgraded to Perform from Outperform at Oppenheimer)
Gapping up
In reaction to strong earnings/guidance:
- CPRT +4.9%,GME +4.8%,DE +4.2%
M&A news:
- AXTA +3.3% (confirms discussions with Nippon Paint for potential acquisition)
Other news:
- CLNT +39.3% (enters into a conditional share swap agreement with Marvel Finance Limited, to acquire Marvel's 51% interest in the issued share capital of Integrated Media Technology)
- EKSO +10.9% (after 40% move higher on Tuesday)
- TIVO +10.5% (ITC gives favorable ruling in U.S. trade case against Comcast)
- CLSN +8% (after 30% move higher on Tuesday)
- SBGL +3.5% (Sibanye-Stillwater and DRDGOLD (DRD) announce surface mining partnership)
- MRVL +1.8% (CEO featured on Mad Money)
- DRE +1.6% (declares special cash dividend of $0.85/share)
- EXEL +1.3% (Exelixis phase 3 CELESTIAL trial results have been accepted as late-breaking presentation at 2018 ASCO-GI Symposium Jan 18--20; to submit supplemental NDA in Q1)
- SSY +1.3% (commences tender offer to repurchase up to 1,562,500 of common shares at $1.60 per share), .
Analyst comments:
- SBS +3.4% (upgraded to Buy from Hold at HSBC Securities)
- D +1.5% (upgraded to Buy from Neutral at BofA/Merrill)
- NTNX +1.3% (initiated with a Buy at Needham)